Filter
5474
Filtered Results: 5474
Text search:
drug
access
Featured
Recommendations
479
New Publications
1433
Language
Document type
No document type
3346
Studies & Reports
872
Guidelines
654
Manuals
230
Strategic & Response Plan
169
Fact sheets
81
Training Material
62
Situation Updates
25
Infographics
16
Resource Platforms
9
Brochures
5
Online Courses
3
App
2
Countries / Regions
India
303
Global
182
Kenya
166
South Africa
142
Uganda
124
Western and Central Europe
121
Ethiopia
120
Nigeria
113
Tanzania
98
Nepal
93
Sierra Leone
88
Malawi
86
Liberia
86
Zambia
80
Africa
77
Myanmar / Burma
77
Latin America and the Carribbean
74
Bangladesh
69
Ghana
66
Rwanda
66
Eastern Europe
65
Ukraine
59
Philippines
47
Namibia
46
Zimbabwe
45
Asia
43
Lesotho
36
Cambodia
36
South–East Asia Region
36
Russia
33
Syria
28
Congo, Democratic Republic of
27
Botswana
26
Indonesia
26
Senegal
25
Mozambique
24
Burkina Faso
21
Colombia
19
Brazil
19
South Sudan
19
Eswatini/ Swaziland
19
Middle East and North Africa
17
East and Southern Africa
17
Cameroon
16
West and Central Africa
15
Tajikistan
14
Haiti
14
Albania
13
USA
13
Venezuela
13
Eastern Europe and Central Asia
13
Germany
12
Thailand
11
Guinea
11
Argentina
11
Vietnam
10
Georgia
10
Pakistan
10
Benin
9
China
9
Afghanistan
9
Moldova
9
Peru
8
Sudan
8
Yemen
8
Laos
7
Armenia
7
Paraguay
7
North Macedonia
6
Mexico
6
El Salvador
6
Western Pacific Region
6
North America
6
Chile
5
Jordan
5
Lebanon
5
Sri Lanka
5
Central African Republic
5
Iraq
5
Turkey
4
Jamaica
4
United Kingdom
4
Bolivia
4
Mali
4
Libya
4
Somalia
4
Timor Leste/ East Timor
3
Iran
3
Kyrgyzstan
3
Spain
3
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Palestine
3
Angola
3
Bhutan
3
Madagascar
3
Serbia
2
Kazakhstan
2
Canada
2
Fiji
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
Gabon
2
Uruguay
2
France
2
Portugal
2
Belarus
2
Southern Africa
2
Romania
2
Poland
2
Honduras
2
North Korea
1
Switzerland
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Malaysia
1
Mongolia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Nicaragua
1
Egypt
1
Greece
1
Chad
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2073
Clinical Guidelines
460
Public Health
262
Women & Child Health
209
Key Resources
157
Capacity Building
79
Pharmacy & Technologies
56
Annual Report MEDBOX
1
Toolboxes
HIV
708
TB
542
Mental Health
532
AMR
269
COVID-19
234
NTDs
217
Pharmacy
161
NCDs
107
Caregiver
106
Rapid Response
85
Ebola & Marburg
82
Refugee
71
Planetary Health
71
Conflict
65
Disability
62
Global Health Education
57
Health Financing Toolbox
48
Cholera
20
Polio
20
Natural Hazards
19
Social Ethics
16
Zika
16
Specific Hazards
14
Malaria
13
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
Recommandations pour une approche de santé publique
L’expansion de la mise en œuvre des approches de suivi du traitement par la réalisation de tests de mesure de la charge virale et de tests de diagnostic chez le nourrisson sera indispensable pour garantir la qualité des soins et des traitements ainsi que le succès des programmes. Le fait de ch...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug consumers. These coupled with rapid spread of res...
Harm reduction: evidence, impacts and challenges
-10-
Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de...
STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems. With stakeholders expressing concern over issues ...
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati...
